gabexate has been researched along with Hyperlipemia in 2 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Camostat-fed rats gained less weight or lost weight, although they consumed more food than the control rat when food intake was adjusted for body weight." | 3.73 | Synthetic protease inhibitor camostat prevents and reverses dyslipidemia, insulin secretory defects, and histological abnormalities of the pancreas in genetically obese and diabetic rats. ( Jia, D; Otsuki, M; Taguchi, M, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jia, D | 1 |
| Taguchi, M | 1 |
| Otsuki, M | 1 |
| Matsui, N | 1 |
| Iwamoto, H | 1 |
| Yoshiyama, N | 1 |
| Nakagawa, S | 1 |
| Takeuchi, J | 1 |
| Teraoka, J | 1 |
| Sasaoka, T | 1 |
| Shoji, T | 1 |
2 other studies available for gabexate and Hyperlipemia
| Article | Year |
|---|---|
Synthetic protease inhibitor camostat prevents and reverses dyslipidemia, insulin secretory defects, and histological abnormalities of the pancreas in genetically obese and diabetic rats.
Topics: Adipose Tissue; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Eating; Esters; Fast | 2005 |
[The effects of heparin-free dialysis on uremic hyperlipidemia in patients on maintenance hemodialysis. I. The change of lipids during a dialysis (author's transl)].
Topics: Gabexate; Guanidines; Humans; Hyperlipidemias; Lipids; Renal Dialysis; Uremia | 1980 |